Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Cogent Biosciences Inc..
Cogent Biosciences Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Cogent Biosciences Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Cogent Biosciences Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Cogent Biosciences Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Cogent Biosciences Inc. and all latest updates of the company are provided.
The 2025 version of Cogent Biosciences Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Cogent Biosciences Inc.- Key Facts
2.2 Cogent Biosciences Inc.- Geographic Locations
2.3 Cogent Biosciences Inc.- Subsidiaries and Affiliates
2.4 Cogent Biosciences Inc.- Business Divisions
2.5 Cogent Biosciences Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Cogent Biosciences Inc. Strategic Analysis Review
3.1 Cogent Biosciences Inc.- Key Strategies
3.2 Cogent Biosciences Inc.- Company Outlook Statement
3.3 Cogent Biosciences Inc.- SWOT Analysis
3.3.1 Cogent Biosciences Inc.- Key Strengths
3.3.2 Cogent Biosciences Inc.- Key Weaknesses
3.3.3 Cogent Biosciences Inc.- Potential Opportunities
3.3.4 Cogent Biosciences Inc.- Potential Threats
3.4 Cogent Biosciences Inc.- Key Competitors
4. Business Description of the Company
4.1 Cogent Biosciences Inc.- Business Overview
4.2 Cogent Biosciences Inc.- Operations by Segment
5 Products and Services Details
5.1 Cogent Biosciences Inc.- Key Products
5.2 Cogent Biosciences Inc.- Key Service Areas
5.3 Cogent Biosciences Inc.- Key Brands
6 Company Developments
6.1 Cogent Biosciences Inc.- Company History
6.2 Cogent Biosciences Inc.- Latest Developments
7 Financial Analysis
7.1 Cogent Biosciences Inc.- Income Statements
7.2 Cogent Biosciences Inc.- Balance Sheet
7.3 Cogent Biosciences Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Cogent Biosciences Inc.- Direct Competitors
8.2 Cogent Biosciences Inc.- Competitor Financial Ratios comparison
8.3 Cogent Biosciences Inc.- Competitor Stock Charts Comparison
8.4 Cogent Biosciences Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!